Detection of E-cadherin gene promoter hypermethylation in plasma of breast cancer patients

张敬杰,欧阳涛,邓国仁,万文徽,徐光炜

DOI: https://doi.org/10.3760/j.issn:1007-631X.2003.11.007

2003-01-01

Abstract:Objective To evaluate the feasibility in early diagnosis, predicting therapeutic effect, recurrence monitoring by examining promoter hypermethylation for cancer-associated genes E-cadherin in cancer tissue and peripheral blood of breast cancer patients. Methods The tumor tissue, paracancer- tissue and the paired plasma were examined for aberrant methylation of E-cadherin gene by methylation-specific PCR in 42 cases of breast cancer and 10 cases of breast benign diseases. Results The incidence of promoter hypermethylation of E-cadherin in tumor tissues was 52.4% and the paired plasma were 33.3%. E-cadherin hypermethylation in plasma samples and tumor samples significantly correlated with each other ( P 0.001). There were no correlations for the aberrant methylation of cancer tissues and plasma with the clinicopathological parameters of patients. None of the aberrant methylation was found in paracancer normal tissues and control group plasma.Conclusion Our findings suggest that aberrant promoter methylation in the plasma can be detected in a substantial proportion of breast cancer patients,and it is useful in early diagnosis ,evaluating therapeutic effect, monitoring recurrence and mass screening.